Exploring the World of Human Cell Lines: Advancing Medical Research at Cytion

Welcome to Cytion's comprehensive guide to human cell lines, where we dive deep into the fascinating world of cellular research. Our extensive collection of cell lines, meticulously tested for purity and genetic integrity, serves as a powerful tool for scientists and researchers worldwide. From cancer studies to drug development, these cell lines play a crucial role in advancing our understanding of human biology and disease.

Breast Cancer Cell Lines
Used to study the molecular and cellular mechanisms of breast cancer. Categorized into several subtypes based on their molecular characteristics.

Applications: Understanding breast cancer heterogeneity and developing targeted therapies.
Leukemia Cell Lines
Essential for studying various subtypes of leukemia, including AML, CLL, and ALL. The LL-100 panel covers 22 entities of human leukemia and lymphoma.

Applications: Studying leukemia biology and drug response.
Liver Cancer Cell Lines
HepG2, Hep3B, and HuH-7 cell lines retain many genetic and molecular characteristics of primary HCCs.

Applications: Studying the pathogenesis and treatment of liver cancer.
Osteosarcoma Cell Lines
Used to study the biology of bone cancer and develop new therapeutic strategies.

Applications: Understanding the genetic and molecular mechanisms underlying osteosarcoma.
Colon Cancer Cell Lines
HT-29, HCT-116, and SW480 cell lines are crucial for studying colorectal cancer.

Applications: Investigating molecular pathways in colon cancer progression and testing drug efficacy.
Ovarian Cancer Cell Lines
SK-OV-3, OVCAR-3, and A2780 cell lines are used to study high-grade ovarian serous adenocarcinoma.

Applications: Understanding molecular mechanisms driving ovarian cancer and developing targeted therapies.
Brain Cancer Cell Lines
U87, U251, and T98G cell lines are used to study glioblastoma and other brain tumors.

Applications: Investigating genetic and molecular alterations in brain cancer and testing new therapeutic approaches.
Lung Cancer Cell Lines
A549, H1299, and H1975 cell lines are widely used to study NSCLC and SCLC.

Applications: Exploring molecular pathways in lung cancer and developing targeted therapies.
Skin Cancer Cell Lines
A375, SK-MEL-28, and HaCaT cell lines are used to study melanoma and other skin cancers.

Applications: Understanding the genetic and molecular mechanisms driving skin cancer and testing new therapeutic strategies.
Mycosis Fungoides and Sezary Syndrome Cell Lines
HUT-78 and SeAx cell lines are used to study these rare types of cutaneous T-cell lymphoma.

Applications: Understanding the pathogenesis of these diseases and developing targeted therapies.

In this article, we will explore the diverse range of human cell lines available at Cytion, their applications in biomedical research, and the advantages and challenges associated with their use. Join us on this exciting journey as we unravel the potential of these powerful tools in the fight against disease and the pursuit of scientific knowledge.

1. MCF-7 Cell Line: A Cornerstone in Breast Cancer Research and Drug Testing

The MCF-7 cell line, derived from the breast adenocarcinoma of a 69-year-old Caucasian woman, has become a cornerstone in breast cancer research since its establishment in 1973. These cells are hormone-responsive and express estrogen receptors (ER), making them an ideal model for studying the biology of ER-positive breast cancers and testing potential therapies targeting this subtype.

MCF-7 cells have been extensively used to investigate the molecular mechanisms underlying breast cancer progression, including cell proliferation, apoptosis, and migration. They have also played a crucial role in the development and testing of various breast cancer drugs, such as tamoxifen and aromatase inhibitors, which have significantly improved patient outcomes.

Furthermore, MCF-7 cells have been employed in studies exploring the effects of hormones, growth factors, and environmental pollutants on breast cancer cell biology. Their relatively low invasive potential has made them a valuable tool for understanding the early stages of breast cancer development and identifying potential biomarkers for early detection and prognosis.

MDA-MB-231 Cells

Organism	Human
Tissue	Breast
Disease	Adenocarcinoma

€430.00*

2. T47D Cell Line: Advancing Breast Cancer Research through Hormone Response Studies

The T47D cell line, isolated from the pleural effusion of a 54-year-old woman with ductal carcinoma, is another widely used model in breast cancer research. Like MCF-7 cells, T47D cells are ER-positive and progesterone receptor (PR) positive, making them valuable for studying hormone-responsive breast cancers.

T47D cells have been particularly useful in investigating the role of hormones, especially progesterone, in breast cancer cell growth and differentiation. They have also been employed to study the cross-talk between estrogen and progesterone signaling pathways, providing insights into the complex hormonal regulation of breast cancer cells.

Moreover, T47D cells have been used to evaluate the efficacy of various anti-estrogenic compounds and to study the mechanisms of resistance to endocrine therapies. Their response to growth factors and cytokines has also been explored, contributing to our understanding of the tumor microenvironment and its influence on cancer progression.

3. MDA-MB-231 Cell Line: Unraveling the Complexities of Triple-Negative Breast Cancer

The MDA-MB-231 cell line, derived from the pleural effusion of a 51-year-old Caucasian woman with metastatic breast cancer, represents a highly aggressive, triple-negative breast cancer (TNBC) subtype. These cells lack the expression of ER, PR, and HER2, making them resistant to standard endocrine therapies and presenting a significant challenge in breast cancer treatment.

MDA-MB-231 cells have been extensively used to study the molecular mechanisms driving the invasive and metastatic behavior of TNBC. They have provided valuable insights into the role of various signaling pathways, such as the PI3K/AKT and MAPK cascades, in promoting cancer cell survival, proliferation, and migration.

Furthermore, MDA-MB-231 cells have been employed in the development and testing of targeted therapies for TNBC, including inhibitors of key signaling molecules and immune checkpoint blockade. Their ability to form tumors in animal models has made them a valuable tool for preclinical studies evaluating the efficacy and safety of novel therapeutic approaches.

In conclusion, the MCF-7, T47D, and MDA-MB-231 cell lines have each played a significant role in advancing our understanding of breast cancer biology and guiding the development of personalized therapies. By providing unique models for hormone-responsive and triple-negative breast cancers, these cell lines continue to be indispensable tools in the fight against this complex and heterogeneous disease.

4. HepG2 Cell Line - A Liver Cancer Research Resource

The HepG2 cell line, derived from the liver tissue of a 15-year-old Caucasian male with hepatocellular carcinoma, has become a well-established model for studying liver cancer biology and drug metabolism. These cells exhibit epithelial morphology and secrete a variety of major plasma proteins, such as albumin, transferrin, and fibrinogen.

HepG2 cells have been extensively used to investigate the molecular mechanisms underlying liver cancer development, including cell cycle regulation, apoptosis, and signal transduction pathways. They have also been employed to study the role of various oncogenes and tumor suppressor genes in hepatocarcinogenesis.

Moreover, HepG2 cells are widely used in toxicological studies to assess the hepatotoxicity of drugs, chemicals, and environmental pollutants. Their ability to metabolize xenobiotics through phase I and II enzymes makes them a valuable tool for predicting drug metabolism and toxicity in the liver.

In addition to their applications in cancer research and toxicology, HepG2 cells have been used to study hepatitis B virus (HBV) infection and replication, as they are permissive to HBV infection. This has contributed to our understanding of the viral life cycle and the development of antiviral therapies.

5. SaOS-2 Cells - An In Vitro Model of Osteosarcoma

The Saos-2 cell line, established from the primary osteosarcoma of an 11-year-old Caucasian girl, represents a valuable model for studying bone cancer biology and osteoblast differentiation. These cells exhibit an epithelial-like morphology and possess the ability to form mineralized bone matrix in vitro.

Saos-2 cells have been used to investigate the molecular mechanisms governing osteosarcoma development and progression, including the role of various signaling pathways, such as the Wnt and Notch cascades, in regulating cell proliferation, differentiation, and survival. They have also been employed to study the effects of growth factors, hormones, and cytokines on osteoblast function and bone matrix formation.

Furthermore, Saos-2 cells have been utilized to evaluate the efficacy of potential therapeutic agents for osteosarcoma, including small molecule inhibitors and immunotherapies. Their ability to form tumors in animal models has made them a useful tool for preclinical testing of novel treatment strategies.

In addition to their applications in cancer research, Saos-2 cells have been used to study bone tissue engineering and regenerative medicine. Their osteoblastic properties have been exploited to develop biocompatible scaffolds and biomaterials for bone repair and regeneration.

6. HT-29 Cell Line: Colon Cancer Research and Experimental Therapeutics

The HT-29 cell line, derived from the colorectal adenocarcinoma of a 44-year-old Caucasian woman, has become a widely used model for studying colon cancer biology and testing potential therapies. These cells exhibit an epithelial morphology and form well-differentiated adenocarcinomas when injected into nude mice.

HT-29 cells have been extensively used to investigate the molecular mechanisms underlying colon cancer development and progression, including the role of oncogenes, tumor suppressor genes, and signaling pathways in regulating cell proliferation, apoptosis, and migration. They have also been employed to study the effects of various growth factors, hormones, and cytokines on colon cancer cell biology.

Moreover, HT-29 cells have been utilized to evaluate the efficacy of potential therapeutic agents for colon cancer, including chemotherapeutics, targeted therapies, and immunotherapies. Their ability to form tumors in animal models has made them a valuable tool for preclinical testing of novel treatment strategies.

In addition to their applications in cancer research, HT-29 cells have been used to study intestinal barrier function and drug absorption. Their ability to form polarized monolayers with tight junctions has made them a useful model for investigating the permeability and transport properties of the intestinal epithelium.

In conclusion, the HepG2, Saos-2, and HT-29 cell lines have each played a significant role in advancing our understanding of liver cancer, osteosarcoma, and colon cancer biology, respectively. By providing unique models for studying cancer development, progression, and treatment, these cell lines continue to be invaluable tools in the fight against these devastating diseases.

7. SK-OV-3 Cells - A Model for High-Grade Ovarian Serous Adenocarcinoma

The SK-OV-3 cell line, derived from the ascites of a 64-year-old Caucasian woman with ovarian cancer, represents a model for high-grade ovarian serous adenocarcinoma. These cells exhibit an epithelial morphology and form moderately differentiated adenocarcinomas when injected into nude mice.

SK-OV-3 cells have been widely used to study the molecular mechanisms underlying ovarian cancer development and progression, including the role of various oncogenes, tumor suppressor genes, and signaling pathways in regulating cell proliferation, apoptosis, and migration. They have also been employed to investigate the effects of hormones, growth factors, and cytokines on ovarian cancer cell biology.

Moreover, SK-OV-3 cells have been utilized to evaluate the efficacy of potential therapeutic agents for ovarian cancer, including chemotherapeutics, targeted therapies, and immunotherapies. Their ability to form tumors in animal models has made them a valuable tool for preclinical testing of novel treatment strategies.

In addition to their applications in cancer research, SK-OV-3 cells have been used to study the mechanisms of chemoresistance in ovarian cancer. Their inherent resistance to several chemotherapeutic agents has made them a useful model for identifying molecular targets and developing strategies to overcome drug resistance.

8. U87MG Cell Line - Glioblastoma Research using U87MG and Its Impact on Brain Cancer Studies

The U87MG cell line, derived from a grade IV glioblastoma of a 44-year-old male patient, has become a widely used model for studying brain cancer biology and testing potential therapies. These cells exhibit an epithelial morphology and form highly invasive tumors when injected into the brains of nude mice.

U87MG cells have been extensively used to investigate the molecular mechanisms underlying glioblastoma development and progression, including the role of various oncogenes, tumor suppressor genes, and signaling pathways in regulating cell proliferation, apoptosis, and invasion. They have also been employed to study the effects of growth factors, cytokines, and the tumor microenvironment on glioblastoma cell biology.

Moreover, U87MG cells have been utilized to evaluate the efficacy of potential therapeutic agents for glioblastoma, including chemotherapeutics, targeted therapies, and immunotherapies. Their ability to form invasive tumors in animal models has made them a valuable tool for preclinical testing of novel treatment strategies, particularly those targeting tumor invasion and angiogenesis.

In addition to their applications in cancer research, U87MG cells have been used to study the blood-brain barrier and drug delivery to the central nervous system. Their ability to form tight junctions and express various transport proteins has made them a useful model for investigating the permeability and transport properties of the blood-brain barrier.

9. A549 Cell Line: A Keystone in Lung Cancer Research

The A549 cell line, derived from the lung adenocarcinoma of a 58-year-old Caucasian male, has become a keystone in lung cancer research. These cells exhibit an epithelial morphology and form well-differentiated adenocarcinomas when injected into nude mice.

A549 cells have been widely used to study the molecular mechanisms underlying lung cancer development and progression, including the role of various oncogenes, tumor suppressor genes, and signaling pathways in regulating cell proliferation, apoptosis, and migration. They have also been employed to investigate the effects of growth factors, cytokines, and the tumor microenvironment on lung cancer cell biology.

Moreover, A549 cells have been utilized to evaluate the efficacy of potential therapeutic agents for lung cancer, including chemotherapeutics, targeted therapies, and immunotherapies. Their ability to form tumors in animal models has made them a valuable tool for preclinical testing of novel treatment strategies.

In addition to their applications in cancer research, A549 cells have been used to study lung injury and repair, as well as the effects of environmental pollutants and toxicants on the respiratory system. Their ability to express various metabolic enzymes and transport proteins has made them a useful model for investigating the biotransformation and toxicity of inhaled substances.

In conclusion, the SK-OV-3, U87MG, and A549 cell lines have each played a significant role in advancing our understanding of ovarian cancer, glioblastoma, and lung cancer biology, respectively. By providing unique models for studying cancer development, progression, and treatment, these cell lines continue to be invaluable tools in the fight against these devastating diseases.